Dopexamine

Dopexamine

Clinical data
ATC code	C01CA14 (WHO)
Identifiers
IUPAC name 4-[2-[6-(phenethylamino)hexylamino]ethyl]benzene-1,2-diol
CAS Number	86197-47-9
PubChem CID	55483
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C22H32N2O2
Molar mass	429.43 g/mol

WikiDoc Resources for Dopexamine
Articles
Most recent articles on Dopexamine Most cited articles on Dopexamine Review articles on Dopexamine Articles on Dopexamine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Dopexamine Images of Dopexamine Photos of Dopexamine Podcasts & MP3s on Dopexamine Videos on Dopexamine
Evidence Based Medicine
Cochrane Collaboration on Dopexamine Bandolier on Dopexamine TRIP on Dopexamine
Clinical Trials
Ongoing Trials on Dopexamine at Clinical Trials.gov Trial results on Dopexamine Clinical Trials on Dopexamine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Dopexamine NICE Guidance on Dopexamine NHS PRODIGY Guidance FDA on Dopexamine CDC on Dopexamine
Books
Books on Dopexamine
News
Dopexamine in the news Be alerted to news on Dopexamine News trends on Dopexamine
Commentary
Blogs on Dopexamine
Definitions
Definitions of Dopexamine
Patient Resources / Community
Patient resources on Dopexamine Discussion groups on Dopexamine Patient Handouts on Dopexamine Directions to Hospitals Treating Dopexamine Risk calculators and risk factors for Dopexamine
Healthcare Provider Resources
Symptoms of Dopexamine Causes & Risk Factors for Dopexamine Diagnostic studies for Dopexamine Treatment of Dopexamine
Continuing Medical Education (CME)
CME Programs on Dopexamine
International
Dopexamine en Espanol Dopexamine en Francais
Business
Dopexamine in the Marketplace Patents on Dopexamine
Experimental / Informatics
List of terms related to Dopexamine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Dopexamine is a β₂-adrenergic receptor agonist.

Template:WikiDoc Sources